Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SeptRx Launches PFO Device Trial, Eyeing Mid-2012 CE-Mark Submission

This article was originally published in The Gray Sheet

Executive Summary

Controversy remains over the clinical benefit of using a patent foramen ovale closure device to prevent strokes or other neurological events, but that has not stopped California startup SeptRx from moving ahead with early stage development of its offering.
Advertisement

Related Content

St. Jude CEO Confident In PFO Device Despite Competitor’s Failure
St. Jude CEO Confident In PFO Device Despite Competitor’s Failure
News In Brief
News In Brief
Enrollment Headaches Cause NMT To Drop Migraine Trial

Topics

Advertisement
UsernamePublicRestriction

Register

MT030334

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel